CIK 0001674416 · Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- EIN
- 473173478
- Phone
- 6173154600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 4 Open-market sale CBO & COO sold 70,000 shares at an average $75.88 ($5,311,564)
- 4 Open-market sale President sold 50,000 shares at $75.00 ($3,750,000)
- 4 Open-market sale Director sold 20,000 shares at an average $73.93 ($1,478,522)
- 4 Open-market sale Executive VP, Head of R&D sold 7,158 shares at an average $75.04 ($537,123)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Executive or director change · Bylaws or fiscal year change · Shareholder vote results
- 8-K Event Regulation FD disclosure · Other events
- 4 Open-market sale Chief Executive Officer sold 17,275 shares at an average $64.68 ($1,117,266)
- 4 Open-market sale President sold 50,000 shares at an average $70.20 ($3,510,020)
- 4 Open-market sale Executive VP, Head of R&D sold 6,700 shares at an average $70.13 ($469,884)
- 4 Open-market sale President sold 50,000 shares at $65.00 ($3,250,000)
Page 25 of 45 · 883 filings